The intricate architecture of the human brain, a network of approximately 100 billion neurons, is largely established during prenatal development, yet a critical process of continuous neural creation persists into adulthood within specific brain regions. New findings emerging from Columbia University Vagelos College of Physicians and Surgeons suggest that this ongoing generation of new neurons, a phenomenon known as adult neurogenesis, plays a significant role in an individual’s resilience against depression. This groundbreaking research provides the first empirical evidence indicating that the creation of new neurons is substantially curtailed in the brains of adults diagnosed with major depressive disorder. Furthermore, the study has illuminated specific molecular pathways that govern this neurogenic process, thereby offering promising insights for the development of innovative therapeutic interventions.
For decades, the prevailing understanding of depression largely centered on imbalances in neurotransmitters, particularly serotonin. However, contemporary scientific thought, as espoused by Maura Dupont, a professor of psychiatry and lead researcher on this study, posits a more complex etiology. "Historically, depression was thought to be a disease of neurotransmitter deficiency, especially serotonin, but we now think that depression stems from multiple issues that affect our neurons’ ability to adapt to stress and changing environments," explains Dupont. This evolving perspective highlights that depression is not a monolithic condition but rather a multifaceted disorder influenced by the brain’s capacity to adapt and respond to internal and external stressors. The inability to generate new neurons, the research suggests, may fundamentally compromise an individual’s adaptive capabilities. "Without the ability to create new neurons, people with depression may not have the resilience to effectively adapt to the environment," Dupont elaborates, underscoring the crucial link between neurogenesis and psychological resilience.
The focal point of this investigation was the hippocampus, a brain region deeply involved in the formation of episodic memories and the processing of emotional responses to environmental stimuli. Crucially, the hippocampus is one of the few areas in the adult brain where new neuron formation continues throughout life. While depression is not exclusively confined to the hippocampus, its profound influence on both memory and emotion has made it a compelling subject of study. Researchers theorize that alterations within this region may contribute to the tendency observed in individuals with depression to interpret experiences through a predominantly negative lens.
The hippocampus’s role in distinguishing between nuanced memories and separating the emotional valence of past experiences from current events is critical for healthy cognitive functioning. This cognitive function, termed "pattern separation," allows individuals to perceive discrete events and their associated emotions as unique occurrences. Impairment in pattern separation can lead to a blurring of distinct memories and their emotional contexts, causing past negative experiences to color present perceptions. Dupont illustrates this phenomenon: "The hippocampus is important for our ability to distinguish between similar but different memories and separate the emotional connotation of past memories and current events." She further elaborates, "This ability is known as pattern separation. When it becomes impaired, individual memories and the emotions attached to them may become less distinct, allowing separate experiences to blend together." A vivid example provided by Dupont highlights the downstream effects: "You may be out with a friend for lunch, but she’s tired and doesn’t talk much. With intact pattern separation, you remember this as a unique event. With impaired pattern separation, it becomes mixed with previous memories of feeling rejected, leading you to think, ‘They’re upset with me’," Dupont explains. "And I see this a lot in my patients, where they can only retrieve negative information from their memories."
Evidence from animal studies has already established a direct correlation between adult neurogenesis and the effectiveness of pattern separation. Moreover, preliminary research involving human patients who underwent radiation therapy to the hippocampus for brain tumors, resulting in the elimination of neurogenesis, further supports this association in humans. "It’s important to emphasize that we do not yet know the complete mechanism, particularly in humans, but the newborn neurons seem to enhance pattern separation because they are especially responsive to new experiences and can be incorporated into new memory circuits more easily, allowing new memories to be stored separately from the old ones," Dupont states. This suggests a potential therapeutic avenue: "Turning neurogenesis back on may be a way to treat depression in some people by rewiring their hippocampus circuit."
The study’s revelations extend beyond the mere cessation of new neuron growth, indicating that the biological impact of depression is far more pervasive within the hippocampal circuitry. The process of new neuron formation is intrinsically linked to a broader hippocampal network responsible for encoding episodic memories along with their emotional significance. The research uncovered widespread molecular dysregulation throughout this entire system, not solely confined to neurogenesis. The affected genes encompass those vital for the formation of new neural connections, the facilitation of communication between brain cells, the provision of cellular energy, and the internal transport of materials within cells.
The trisynaptic circuit, the hippocampus’s primary functional pathway for the establishment of new emotional memories, also exhibited signs of inflammation and cellular stress in individuals with depression. To arrive at these comprehensive findings, the research team meticulously analyzed nearly half a million individual brain cells sourced from individuals with depression and a control group, collected shortly after their passing. Employing a suite of cutting-edge techniques, the scientists were able to measure the genetic activity of each cell and identify alterations in cellular proteins. This extensive dataset provided an unprecedented granular view of cellular function and pinpointed the precise locations of affected cells within the hippocampal circuit.
The detailed analysis unveiled aberrant gene activity in several genes previously implicated in major depressive disorder through genetic variant studies. Furthermore, disruptions were observed in other genes through epigenetic modifications, which may serve as biological markers reflecting the impact of environmental influences. Epigenetic mechanisms act as regulatory "dimmer switches," modulating gene expression without altering the underlying DNA sequence. "These are like dimmer switches that control how active genes are, and they are affected by life experiences such as stress, learning, aging, chemicals, etc.," Dupont explains, highlighting the dynamic interplay between genes and environment. The broad spectrum of molecular changes observed may also shed light on the considerable variability in how depression manifests across individuals. "Overall, the wide range of effects we found could reflect different pathogenetic mechanisms, perhaps indicating that depression is not just one disease," Dupont posits, suggesting a paradigm shift towards understanding depression as a spectrum of related disorders rather than a singular entity.
Despite these significant advancements, the underlying biology of depression remains incompletely understood, according to Dupont. However, studies like this, which meticulously define the disorder at the cellular and molecular levels, hold the promise of identifying novel therapeutic targets. The research team, led by Dupont and her colleagues, harbors the ambition of classifying depression based on its molecular characteristics, drawing a parallel to the advancements seen in cancer research. "We want to reclassify depression based on its molecular features, similar to what has been done in cancer," Dupont states. "Classifying cancers based on their cellular characteristics, not their locations, has led to new and improved treatments. We hope the same will be true for depression and other psychiatric or brain diseases." This endeavor signifies a move towards a more personalized and biologically informed approach to treating mental health conditions. The findings of this pivotal study, titled "Dysregulated adult hippocampal neurogenesis in major depressive disorders," were published on August 21, 2026, in the esteemed journal Nature Medicine. The research was a collaborative effort involving numerous scientists from Columbia University and the New York State Psychiatric Institute, with specific contributions from Madeleine S. Peng, Jialin Jiang, Lucia Polizzi, Tiancheng Shi, Rakshitha Ramkumar, Victor O. Anosike, Giulia Guasoni, Alexandra M. Wamalwa, Madeline B. Mariani, Cheick A. Sissoko, Alexandria N. Tartt, Camille Fulmore, Gorazd B. Rosoklija, Yung-yu Huang, Victoria Arango, Shujuan T. McDonald, Natasha Bitoljanu (from Ss. Cyril and Methodius University, Macedonia), Joseph J. Mann, Phi T. Nguyen, Andrew J. Dwork, Lewis M. Brown, René Hen, Hanga Galfalvy, and Maura B. Dupont. The research was primarily conducted within the Maura Dupont laboratory at Columbia University Irving Medical Center and the New York State Psychiatric Institute. Advanced genomic sequencing was performed at the JP Sulzberger Columbia Genome Center, data clustering was managed at Columbia’s Center for Computational Biology and Bioinformatics, and proteomic analyses were executed at Columbia University’s Department of Biology’s Quantitative Proteomics and Metabolomics Center.
About the Author
